Victrex

VCTBasic Materials
769.00GBX
-0.65%
Market Cap
669.43M
Volume
54.89k
23% of avg
P/E Ratio
0.11
EPS (TTM)
72.23
Beta
0.64
Day Range
762.00p - 792.00p
52 Week Range
706.00p769.00p1,224.00p
769.00p

Upcoming Events

June 27, 2025
Payment of interim dividend
Late Q4 2025
Expected first commercial PEEK Knee in the market
High Impact Event
Early 2026
Anticipated volume scale-up for 'Magma' composite pipe solution
High Impact Event
VCT
NEUTRAL

Victrex Appoints Investec as Joint Corporate Broker

The specialty chemicals company has appointed Investec Bank plc as a Joint Corporate Broker, working alongside the existing broker J.P. Morgan Securities plc.

VCT
NEUTRAL

Victrex Announces Holding Change

The specialty chemicals company has announced a change in shareholding, with Norges Bank increasing its stake to 8.81%.

VCT
NEUTRAL

Victrex Announces Holding Change

The specialty chemicals company has announced a change in shareholding, with Norges Bank increasing its stake to 7.43%.

VCT
NEUTRAL

Victrex Announces Holding Change

The specialty chemicals company has announced a change in shareholding, with FIL Limited increasing its stake to 9.766%.

VCT
NEUTRAL

Victrex Announces Director Share Purchase

The specialty chemicals company announces a non-executive director has purchased shares in the business.

VCT
BAD

Victrex Reports Mixed H1 Results: Revenue Up, Profits Down Amid Headwinds

The specialty chemicals manufacturer reported mixed H1 results, with revenue up 5% but profits down 17%. Facing headwinds from FX, China operations, and Medical segment weakness, the outlook remains cautious.

VCT
GOOD

Victrex's 'Magma' programme advances with TechnipFMC contract award

The specialty chemicals company has secured a major contract award that supports the development and commercialization of its 'Magma' programme, representing a significant growth opportunity.

VCT
NEUTRAL

Victrex Director Increases Shareholding

The prominent specialty chemicals company announces a non-executive director has purchased additional shares.

VCT
NEUTRAL

Victrex Delivers Solid Q1 Performance Amid Mixed Trading Conditions

The specialty chemicals company reports a solid start to the year, with Q1 revenue and volume growth, but trading conditions remain mixed, particularly in the Medical segment.

VCT
NEUTRAL

Ameriprise Financial Increases Stake in Victrex

Regulatory update on shareholding changes for this specialty chemicals company.